» Articles » PMID: 32934910

Kaposi's Sarcoma-associated Herpesvirus Protein ORF75 Among HIV-1 Patients in Kenya

Overview
Journal Afr J Lab Med
Date 2020 Sep 16
PMID 32934910
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Histology is used to identify Kaposi's sarcoma (KS) in countries with low resources to fund healthcare costs. Approximately 95% of KS cases can be detected using a polymerase chain reaction.

Objective: To determine the presence of the open reading frame 75 (ORF75) gene associated with Kaposi's sarcoma herpes virus among HIV-1/AIDS patients and to describe morphological presentations of KS.

Methods: This was a retrospective, descriptive study of archived tissue blocks collected from 2013 to 2016. Haematoxylin and eosin staining was used to identify KS. Deoxyribonucleic acid from archived tissue blocks was extracted and a nested polymerase chain reaction was used to detect the ORF75 gene.

Results: All 81 cases in this study had been diagnosed as HIV-1 positive, of which 68 had hallmark features of KS in the histology report and 13 had features suggestive of KS ('KS-like'). Microscopic identification of KS by haematoxylin and eosin staining was considered a significant indicator of KS herpes virus ORF75 gene positivity ( = 0.002). The ORF75 gene was detected in 60.5% (49/81) of tissue blocks; 27.2% were men (22/81) and 33.3% were women (27/81). The ORF75 gene was observed to be present in up to 15.4% (2/13) of the cases reported to have KS-like features.

Conclusion: Following the initial diagnosis of KS by histology, the ORF75 gene was fur-ther detected from both cases that had hallmark features of KS as well as among cases with KS-like fea-tures.

Citing Articles

The role of infections in the causation of cancer in Kenya.

Tuei V, Maiyoh G, Ndombera F Cancer Causes Control. 2022; 33(12):1391-1400.

PMID: 36087193 DOI: 10.1007/s10552-022-01625-3.


Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, Congo.

Malonga G, Jary A, Leducq V, Moudiongui Mboungou Malanda D, Boumba A, Chicaud E Sci Rep. 2021; 11(1):17442.

PMID: 34465868 PMC: 8408137. DOI: 10.1038/s41598-021-97070-4.


African laboratory medicine in the time of COVID-19.

Okeke I Afr J Lab Med. 2021; 9(1):1447.

PMID: 33392058 PMC: 7756673. DOI: 10.4102/ajlm.v9i1.1447.

References
1.
Krown S, Roy D, Lee J, Dezube B, Reid E, Venkataramanan R . Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr. 2011; 59(5):447-54. PMC: 3302934. DOI: 10.1097/QAI.0b013e31823e7884. View

2.
Fulciniti F, De Chiara A, Apice G, Petrillo A, Botti G, Feroce F . Fine-needle cytology of Kaposi's sarcoma in an intramammary lymphnode: report of one case. Diagn Cytopathol. 2012; 40 Suppl 2:E149-52. DOI: 10.1002/dc.21783. View

3.
El-Mallawany N, Kamiyango W, Slone J, Villiera J, Kovarik C, Cox C . Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335. PMC: 4833299. DOI: 10.1371/journal.pone.0153335. View

4.
Begre L, Rohner E, Mbulaiteye S, Egger M, Bohlius J . Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis. Int J Cancer. 2016; 139(4):776-83. PMC: 5563519. DOI: 10.1002/ijc.30129. View

5.
Letang E, Lewis J, Bower M, Mosam A, Borok M, Campbell T . Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK. AIDS. 2013; 27(10):1603-13. DOI: 10.1097/QAD.0b013e328360a5a1. View